drugset / Trial / NCT04202536
Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate
RandomizedParallel-groupOpen-labelTreatment
Summary
A research study to observe the safety, efficacy and tolerability of switching from Tenofovir Disoproxil Fumarate to Besifovir dipivoxil maleate in patients with chronic hepatitis B
Timeline
- Start
- 2019-05-29
- Primary completion
- 2021-06
- Completion
- 2021-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Besifovir | Other / unclassified | 150 mg | — |
| Comparator | Tenofovir disoproxil fumarate | Small molecule | 300 mg | Oral |
| Background | L-carnitine | Other / unclassified | 660 mg | — |